Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients-Reference-Cited by-同舟云学术

Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients

Published:2023-03-29 Issue:2 Volume:199 Page:363-370
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Acevedo Francisco,Walbaum Benjamín,Camus Mauricio,Manzor Manuel,Muñiz Sabrina,Medina Lidia,Petric Militza,Reyes Paula,Domínguez Francisco,Puschel Klaus,Merino Tomas,Bravo M. Loreto,Pinto Mauricio P.,Ibáñez Carolina,Hughes Kevin,Sánchez César^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06909-z.pdf

Reference31 articles.

1. Adaniel C, Salinas F, Donaire JM, Bravo ME, Peralta O, Paredes H et al (2019) Non-BRCA1/2 variants detected in a high-risk Chilean cohort with a history of breast and/or ovarian cancer. J Glob Oncol. https://doi.org/10.1200/JGO.18.00163

2. Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A et al (2019) Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol 37:1305–1315. https://doi.org/10.1200/JCO.18.01854

3. Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25–33. https://doi.org/10.1002/CNCR.29010

4. Makhnoon S, Tran G, Levin B, Mattie KD, Dreyer B, Volk RJ et al (2021) Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes. Cancer 127:3605–3613. https://doi.org/10.1002/cncr.33668

5. Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G et al (2019) Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol 37:453–460. https://doi.org/10.1200/JCO.18.01631

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilocus inherited neoplasia allele syndrome: report of uncommon combinations between CHEK2/ATM and BRCA1/CDKN2A genes;ecancermedicalscience;2024-05-10

2. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico;International Journal of Gynecologic Cancer;2024-03-06